Koji Higuchi

Development of stabilized fuzapladib solution for injection: forced degradation study and pharmacokinetic evaluation

S. Onoue, Hideyuki Sato, Kohei Yamada, 2022, Pharmaceutical development and technology.

Nanocrystal solid dispersion of fuzapladib free acid with improved oral bioavailability

S. Onoue, Hideyuki Sato, Kohei Yamada, 2022, Biopharmaceutics & drug disposition.

Species differences in the biopharmaceutical properties of fuzapladib sodium monohydrate in rats, cats, and dogs

S. Onoue, Hideyuki Sato, Kohei Yamada, 2022, Pharmacy & Pharmacology International Journal.

Polylysine-Containing Hydrogel Formulation of Fuzapladib, Inhibitor of Leukocyte-Function Associated Antigen-1 (LFA-1) Activation, for Sustained Release

S. Onoue, Hideyuki Sato, Kohei Yamada, 2023, Molecules.